SCHEMBL32670066

SCHEMBL32670066

COc1cc(/C(O)=C(\C#N)C(=O)N(C)CC#CCc2ccccn2)cc([N+](=O)[O-])c1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 6/20 0.47
COMT P21964 5/20 0.45
EGFR P00533 2/20 0.36
ALDH1A1 P00352 2/20 0.36
MEN1 O00255 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
THRB P10828 1/20 0.36
HTT P42858 1/20 0.36
RECQL P46063 1/20 0.36
BLM P54132 1/20 0.36
KMT2A Q03164 1/20 0.36
MCL1 Q07820 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
TTR P02766 1/20 0.35
ABCB1 P08183 1/20 0.35
ABCC1 P33527 1/20 0.35
AKR1C3 P42330 1/20 0.35
AKR1C1 Q04828 1/20 0.35
NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32670093 0.90 FTO (0.56) FTOCOMTALDH1A1MEN1MAPT
SCHEMBL32669898 0.90 FTO (0.58) FTOCOMTEGFRALDH1A1MEN1
SCHEMBL32670146 0.90 FTO (0.50) FTOCOMTEGFRALDH1A1MEN1
SCHEMBL32669807 0.89 FTO (0.46) FTOCOMTALDH1A1MAPTKMT2A
SCHEMBL32670055 0.85 FTO (0.45) FTOCOMTEGFRALDH1A1MEN1
SCHEMBL32670000 0.84 FTO (0.49) FTOCOMTEGFRALDH1A1MEN1
SCHEMBL32670049 0.83 FTO (0.53) FTOCOMTEGFRALDH1A1MEN1
SCHEMBL32670156 0.83 FTO (0.48) FTOCOMTEGFRALDH1A1MEN1
SCHEMBL32669670 0.82 FTO (0.47) FTOCOMTEGFRALDH1A1MEN1
SCHEMBL32670126 0.82 FTO (0.56) FTOCOMTEGFRALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035341-A1 FTO INHIBITORS RPXDS CO LTD (CN) 2026-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035341-A1 FTO INHIBITORS FTO, LDLR, GPR119 FTO 1/4885COMT 52/4885EGFR 897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.